COVID-19 trials registries data warehouse

 Return to trial list

Trial - NCT04627519


Column Value
Trial registration number NCT04627519
Full text link
Last imported at : Nov. 14, 2020, 11:31 p.m.
Source : ClinicalTrials.gov

First author
Last imported at : June 12, 2021, 12:32 a.m.
Source : ClinicalTrials.gov

Keri Lestari, PhD

Contact
Last imported at : June 12, 2021, 12:32 a.m.
Source : ClinicalTrials.gov

lestarikd@unpad.ac.id

Registration date
Last imported at : Nov. 14, 2020, 11:31 p.m.
Source : ClinicalTrials.gov

2020-11-13

Recruitment status
Last imported at : June 5, 2023, 8 a.m.
Source : ClinicalTrials.gov

Unknown

Study design
Last imported at : Nov. 14, 2020, 11:31 p.m.
Source : ClinicalTrials.gov

RCT

Allocation
Last imported at : Nov. 14, 2020, 11:31 p.m.
Source : ClinicalTrials.gov

Randomized

Design
Last imported at : Nov. 14, 2020, 11:31 p.m.
Source : ClinicalTrials.gov

Parallel

Masking
Last imported at : Nov. 14, 2020, 11:31 p.m.
Source : ClinicalTrials.gov

Open label

Center
Last imported at : Nov. 14, 2020, 11:31 p.m.
Source : ClinicalTrials.gov

multi-center

Study aim
Last imported at : Nov. 14, 2020, 11:31 p.m.
Source : ClinicalTrials.gov

Treatment

Inclusion criteria
Last imported at : Nov. 16, 2021, 6:30 p.m.
Source : ClinicalTrials.gov

inclusion criteria: male and female patients aged ≥ 18 years to 50 years old, who recently admitted as in-patients and have not received any standard of care yet, with covid-19 confirmed by pcr with mild to moderate symptoms. female subjects of child-bearing age agree to take effective contraceptive measures during the study until seven days of the last oral medication of study product; willing to receive a random assignment to any designated treatment group and not participating in another study at the same time; willing for not using any other immunomodulator or treatment that might bias the study patient willing to provide informed consent.

Exclusion criteria
Last imported at : Nov. 16, 2021, 6:30 p.m.
Source : ClinicalTrials.gov

any allergy to any composition of rhea health tone®; pregnant and breastfeeding; history and co-morbid of severe underlying disease where treatment and follow up is not likely to be beneficial to the patient based on physician judgment (e.g. retinopathy, cardiovascular disease (qtc > 500 mdet (narrow qrs); qtc ≥ 550 mdet (wide qrs)), heart arrhythmia, uncontrolled diabetes mellitus, hypertension, chronic pulmonary disease, asthma, chronic kidney disease (creatinine > 2x upper limit of normal), liver disease (sgot/sgpt > 2x limit of normal), chronic neurological disease, or etc.). this includes people requiring care in designated supported living facilities and severe dementia; possibility of being transferred to a non-study-hospital within 72 hours. history of autoimmune disease, cancer, hiv aids.

Number of arms
Last imported at : Nov. 14, 2020, 11:31 p.m.
Source : ClinicalTrials.gov

2

Funding
Last imported at : Nov. 14, 2020, 11:31 p.m.
Source : ClinicalTrials.gov

Universitas Padjadjaran

Inclusion age min
Last imported at : Nov. 14, 2020, 11:31 p.m.
Source : ClinicalTrials.gov

18

Inclusion age max
Last imported at : Nov. 14, 2020, 11:31 p.m.
Source : ClinicalTrials.gov

50

Countries
Last imported at : Feb. 11, 2021, 12:31 a.m.
Source : ClinicalTrials.gov

Indonesia

Type of patients
Last imported at : Nov. 14, 2020, 11:31 p.m.
Source : ClinicalTrials.gov

Mild/moderate disease at enrollment

Severity scale
Last imported at : Nov. 14, 2020, 11:31 p.m.
Source : ClinicalTrials.gov

2: Mild/moderate disease at enrollment

Total sample size
Last imported at : Feb. 11, 2021, 12:31 a.m.
Source : ClinicalTrials.gov

85

primary outcome
Last imported at : Nov. 14, 2020, 11:31 p.m.
Source : ClinicalTrials.gov

Length of stay

Notes
Last imported at : Nov. 14, 2020, 11:31 p.m.
Source : ClinicalTrials.gov

None

Phase
Last imported at : Nov. 16, 2021, 6:30 p.m.
Source : ClinicalTrials.gov

Phase 2

Arms
Last imported at : Nov. 14, 2020, 11:31 p.m.
Source : ClinicalTrials.gov

[{"arm_notes": "", "treatment_id": 93, "treatment_name": "Antioxidant therapy", "treatment_type": "Others pharmacological treatment", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "", "treatment_id": 2188, "treatment_name": "Standard of care", "treatment_type": "Standard of care", "pharmacological_treatment": "Standard of care"}]